Long
Aggiornato

Small account play with potential upcoming COVID catalyst

338
Vaccine play: “Four vaccine candidates developed from VXRT's proprietary VAAST platform were assessed in mouse models and elicited a strong immune response.” (finance.yahoo.com/news/advantage-vaxart-sharp-pullback-says-200653838.html)
  • Potential upcoming catalyst of a Phase 1 trial

    As of last week, down 73% since the yearly high, has begun to reverse.

    Very oversold on SlowStoch and has been for nearly a month

    Below 100day SMA, only slightly above 200day SMA

Fib targets above, can use 0 fib below for stop loss.
Trade chiuso: obiettivo raggiunto
Even as a late add this was a big winner.
Trade attivo
Re-entered, but chasing slightly. Hoping for a break to 9.47 and above.

Declinazione di responsabilità

Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.